• Profile
Close

Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma

BMC Urology Dec 08, 2021

Yanagi M, Hamasaki T, Akatsuka J, et al. - In patients who underwent retroperitoneoscopic nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC), a high chance of occurrences of intravesical recurrence (IVR) in 1 and 3 years post-RNU was observed when the pneumoretroperitoneum time was prolonged (≥ 210 min) and in patients with positive urine cytology, respectively. For such cases, strict follow-up post-RNU is more likely advised.

  • IVR represents one of the major concerns of patients with UTUC treated with nephroureterectomy.

  • This study included 73 patients treated with RNU for non-metastatic UTUC, without a history of or concomitant bladder cancer.

  • Occurrence of subsequent IVR post-RNU was evident in 18 (24.7%) patients during median follow-up of 39.1 months.

  • IVR-free survival rates, at 1 and 3 years, were 85.9% and 76.5%, respectively.

  • As shown in the Fisher exact test, prolonged pneumoretroperitoneum time of ≥ 210 min and positive urine cytology were risk factors for IVR in 1- and 3- years post-RNU, respectively.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay